Fetal vesico-amniotic shunt for lower urinary tract outflow obstruction
National Institute for Health and Clinical Excellence
Record ID 32006001604
English
Authors' objectives:
This study aims to assess the current evidence on fetal vesico-amniotic shunt for lower urinary tract outflow obstruction.
Authors' recommendations:
1 Guidance
1.1 Current evidence on the safety and efficacy of fetal vesico;amniotic shunt for lower urinary tract outflow obstruction does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research.
1.2 Clinicians wishing to undertake insertion of a fetal vesico;amniotic shunt for lower urinary tract outflow obstruction should take the following actions.
: Inform the clinical governance leads in their Trusts.
: Ensure that parents understand the uncertainty about the procedure-s safety and efficacy and provide them with clear written information.In addition, use of the Institute's information for patients ('Understanding NICE guidance') is recommended (available from www.nice.org.uk/IPG202publicinfo).
: Audit and review clinical outcomes of all patients having fetal vesico;amniotic shunt for lower urinary tract outflow obstruction.
1.3 This procedure should only be performed in centres specialising in invasive fetal medicine and in the context of a multidisciplinary team, which may include a consultant in fetal medicine, a paediatric urologist, a neonatologist and a specialist midwife.
1.4 Publication of safety and efficacy outcomes will be useful. A randomised trial (PLUTO) comparing fetal vesico;amniotic shunt with no treatment is in progress. Clinicians are encouraged to enter patients into this trial or the associated registry (www.pluto.bham.ac.uk and www.trials.bham.ac.uk/PLUTO). The Institute may review the procedure upon publication of further evidence.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/guidance/IPG202
Year Published:
2006
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Fetal Diseases
- Urinary Tract
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.